The present invention relates generally to apparatus, systems, and methods for use in a lumen; and more particularly to a valve apparatus, systems, and methods for use in the vasculature system.
The venous system of the legs uses valves and muscles as part of the body's pumping mechanism to return blood to the heart. Venous valves create one way flow to prevent blood from flowing away from the heart. When valves fail, blood can pool in the lower legs resulting in swelling and ulcers of the leg. The absence of functioning venous valves can lead to chronic venous insufficiency.
Techniques for both repairing and replacing the valves exist, but are tedious and require invasive surgical procedures. Direct and indirect valvuloplasty procedures are used to repair damaged valves. Transposition and transplantation are used to replace an incompetent valve. Transposition involves moving a vein with an incompetent valve to a site with a competent valve. Transplantation replaces an incompetent valve with a harvested valve from another venous site. Prosthetic valves can be transplanted into the venous system, but current devices are not successful enough to see widespread usage.
Embodiments of the present invention are directed to an apparatus, system, and method for valve replacement or augmentation. For example, the apparatus can include a valve that can be used to replace or augment an incompetent valve in a body lumen. Embodiments of the valve can include a frame and cover that can be implanted through minimally-invasive techniques into the body lumen. In one example, embodiments of the apparatus, system, and method for valve replacement or augmentation may help to maintain antegrade blood flow, while decreasing retrograde blood flow in a venous system of individuals having venous insufficiency, such as venous insufficiency in the legs.
The Figs. herein follow a numbering convention in which the first digit or digits correspond to the drawing Fig. number and the remaining digits identify an element or component in the drawing. Similar elements or components between different Figs. may be identified by the use of similar digits. For example, 110 may reference element “10” in
The frame 102 of valve 100 can have a number of configurations. For example, in the various embodiments the frame 102 can include at least a first planar surface 106 having a predetermined width 108. In one embodiment, the first planar surface 106 extends along the entire length of the frame 102, as illustrated in the embodiment of
As illustrated in
The predetermined width 108 of the frame 102, in addition, can have a uniform value over the length of frame 102. Alternatively, the predetermined width 108 of the frame 102 can have predetermined variations over the length of the frame 102. For example, the predetermined width 108 can be larger (i.e., wider) along one or more intermediate portions 112 of the frame 102 as compared to corner portions 114 of the frame 102. The exact configuration and values for the predetermined width 108 can depend on many patient factors, including, but not limited to, where the valve 100 is to be implanted and the physiological environment in which the valve 100 is to be implanted.
In addition, the intermediate portions 112 of the frame 102 can further include at least a partial helical configuration 116. For example, the first planar surface 106 of frame 102 can follow the partial helical configuration 116 extending along a longitudinal central axis 118 of the frame 102 such that the first planar surface 106 maintains an essentially symmetrical relation to the outer diameter 110 of the frame 102. In one embodiment, this configuration of the frame 102 allows the first planar surface 106 along the intermediate portions 112 to essentially follow along a tubular shaped path extending along the longitudinal central axis 118. In other words, the first planar surface 106 rotates (e.g., twists) as it extends along the longitudinal central axis 118 to essentially track the tubular (e.g., circular) surface along points that cross right sections of the tubular surface at an oblique angle. In addition, this configuration of the frame 102 can further allow the first planar surface 106 to essentially follow the tubular (e.g., circular) path as the frame 102 moves between a compressed and expanded state, as will be more fully discussed herein.
In the various embodiments described herein, the corner portions 114 of the frame 102 can provide a spring force to counter radial compression of the frame 102. As will be appreciated, additional spring force can be imparted to the frame 102 from the compression of the partial helical configuration 116 of the intermediate portions 112 of the frame 102 as well. For example, as all or a portion of the frame 102 is radially compressed towards the longitudinal central axis 118, both the corner portions 114 and the partial helical configuration 116 of the frame 102 can resiliently bend (e.g., the spiral shape of the partial helical configuration is turned more tightly) to store elastic force (e.g., elastic potential energy) that allows the frame 102 to expand radially so as to return towards its uncompressed state.
As illustrated in
As illustrated in
As illustrated in
In the various embodiments, the frame 102 can provide symmetrical relationships for the members 120, 122, 124 and 126 and the vertices 128, 130, 134 and 136. For example, as illustrated in
In additional embodiments, the frame 102 can also provide radial symmetry for the members 120, 122, 124 and 126 and the vertices 128, 130, 134 and 136. For example,
As will be appreciated, the various members and vertices of the frame 102 need not necessarily, however, display a symmetrical relationship in order to practice the embodiments of the present invention. For example, in an additional embodiment the radial relationship of the first member 120 and the second member 122 can be set apart approximately ninety (90) degrees or greater relative each other around the longitudinal central axis 118 of the frame 102. In which case the first member 120 and the third member 124, and the second member 122 and the fourth member 126 can be set apart approximately ninety (90) degrees or less relative each other around the longitudinal central axis 118 of the frame 102. Other radial relationships are also possible.
As illustrated in
For example, the frame 102 can have a similar cross-sectional geometry along its length.
Alternatively, the frame 102 can include portions having the first planar surface 106 with the other portions of the frame 102 surfaces having a non-planar configuration. For example,
While the members 220, 222, 224, and 226 are illustrated herein as having a planar cross-sectional configuration, other configurations are also possible. For example,
In addition,
In addition to changes in cross-sectional geometry, there can also be changes in the widths 308 and/or the diameters of the round and/or semi-round geometries relative to each other along the length of the frame 302. Changes in shapes, cross-sectional geometries, widths and/or diameters can depend on many patient factors, including, but not limited to, where the valve 300 is to be implanted and the physiological environment in which the valve 300 is to be implanted.
As will be appreciated, the embodiments discussed herein are not intended to limit the present invention, as it is appreciated that other cross-sectional geometries and combinations thereof are also possible. As such, the present invention should not be limited to the illustration of the frame 102 in
Referring again to
Referring now to
The elastic regions of the frame 102 also allow valve 100 to elastically and repeatably travel between a collapsed state and an expanded state.
In addition to the illustrated corner portions 114, the elastic regions can further include, but are not limited to, other shapes for the valve frame 102 that allow for repeatable travel between the collapsed state and the expanded state. For example, the elastic regions can include integrated springs having a circular or an elliptical loop configuration. Other shapes are also possible.
The embodiments of the frame, such as frame 102 in
The materials used in constructing frame embodiments can also be pre- and post-treated. For example, the material characteristics of the frame can be modified by imparting to the corner portions, e.g. 114, 214 and 314, a radial arc that flares the frame outward from the longitudinal central axis. In one embodiment, the radial arc may be sufficiently large such that portions of the frame at the corners may extend beyond the outer diameter of the frame as defined by the first planar surface. Illustrations of such a radial arc, such as those described herein, can be found in co-pending U.S. patent application Ser. No. 11/150,331, filed on Jun. 10, 2005 and entitled “Venous Valve Frame, System, and Method”, which is incorporated herein by reference in its entirety.
The embodiments of the frame, such as frame 102 in
The frame embodiments can be formed from a number of materials. For example, the frame can be formed from a biocompatible metal, metal alloy, polymeric material, or combination thereof. As discussed herein, the frame can be self-expanding or balloon expandable. In addition, the frame can be configured so as to have the ability to move radially between the collapsed state and the expanded state. To accomplish this, the material used to form the frame should exhibit an elastic modulus and a yield stress that can accommodate large elastic strains and can recover from elastic deformations. Examples of suitable materials include, but are not limited to, medical grade stainless steel (e.g., 316L), titanium, tantalum, platinum alloys, niobium alloys, cobalt alloys, alginate, or combinations thereof. Additional frame embodiments may be formed from a shape-memory material, such as shape memory plastics, polymers, and thermoplastic materials which are inert in the body. Shaped memory alloys having superelastic properties generally made from ratios of nickel and titanium, commonly known as nitinol, are also possible materials. Other materials are also possible.
Frame can be expanded to provide a lumen (e.g., 105 in
In one embodiment, the frame can further include one or more anchoring elements. For example, the one or more anchoring elements can include, but are not limited to, one or more barbs 150 projecting from the frame 102. The valve can further include one or more radiopaque markers (e.g., tabs, sleeves, welds, coatings such as formed by plating or dipping). For example, one or more portions of the frame can be formed from a radiopaque material. Radiopaque markers can be attached to and/or coated onto one or more locations along the frame. Examples of radiopaque material include, but are not limited to, gold, tantalum, and platinum. The position of the one or more radiopaque markers can be selected so as to provide information on the position, location and orientation of the valve during its implantation.
The embodiments of the valve further include the cover. In one embodiment, cover 104 can be located over at least the first planar surface 106 of the frame 102 so as to cover at least part of an outer surface 152 of the frame 102. For example, the cover 104 can extends over the outer surface 152 of the frame 102 so as to cover the outer surface 152 of the frame 102 thereby limiting, or eliminating, the exposure of the outer surface 152 of the frame 102.
In an additional example, the cover 104 can extend between each of the members 120, 122, 124, and 126 and vertices 128, 130, 134 and 136 to surround the circumference of the frame 102. Examples of are generally illustrated in
As discussed herein, cover 604 includes surfaces defining the reversibly sealable opening 656 for unidirectional flow of a liquid through the lumen 605. For the embodiment illustrated in
As illustrated, the first valve leaflet 662 and the second valve leaflet 664 include a region 666 of the cover 604 that can move relative the frame 602. The region 666 of the cover 604 can be unbound (i.e., unsupported) by the frame 602 and extends between the first connection point 658 and the second connection point 660 of the valve 600. This configuration permits the reversibly sealable opening 656 to open and close in response to the fluid pressure differential across the valve leaflets 662 and 664.
For example, under antegrade fluid flow (i.e., positive fluid pressure) from a first end 668 towards a second end 670 of the valve 600, the first and second valve leaflets 662 and 664 can expand toward the inner surface 654 to create an opening through which fluid is permitted to move. In one example, the first valve leaflet 662 and the second valve leaflet 664 can each expand to define a semi-tubular structure when fluid opens the reversibly sealable opening 656. An example of the open configuration for the valve is shown in
Under a retrograde fluid flow (i.e., negative fluid pressure) from the second end 670 towards the first end 668, the first and second valve leaflets 662 and 664 can move away from the inner surface 654 as the valve leaflets 662 and 664 begin to close valve 600. In one example, a pocket exists between the frame 602 and each of the first and second valve leaflets 662 and 664. The pocket allows fluid from the retrograde flow to develop pressure on a first major face 672 of the first and second valve leaflets 662 and 664, for example, as illustrated in
Referring again to
The first valve leaflet 162 and the second valve leaflet 164 can have a variety of sizes and shapes. For example, each of the first valve leaflet 162 and the second valve leaflet 164 can have a similar size and shape. In addition, each of the first valve leaflet 162 and the second valve leaflet 164 can include opposed first and second major surfaces 172 and 178, respectively. Each first major surface 172 of the first valve leaflet 162 and the second valve leaflet 164 can be oriented to face the second end 170 of valve 100.
Each of the first valve leaflet 162 and the second valve leaflet 164 can further provide the sealing surface 176 formed by portions of the first valve leaflet 162 and the second valve leaflet 164, where the sealing surface 176 can engage to define the closed configuration of valve 100. Sealing surface 176 of the first valve leaflet 162 and the second valve leaflet 164 can separate to provide for an open configuration of valve 100. In an additional example, each of the first valve leaflet 162 and the second valve leaflet 164 need not have a similar size and shape (i.e., the valve leaflets can have a different size and shape with respect to each other).
In one embodiment, each of the first valve leaflet 162 and the second valve leaflet 164 includes sufficient excess material spanning frame 102 such that fluid pressure (e.g., antegrade flow) acting on the second major surface 178 of the first valve leaflet 162 and the second valve leaflet 164 forces the valve 100 into an open configuration. The first valve leaflet 162 and the second valve leaflet 164 each further include an arcuate edge 180 positioned adjacent each other along a substantially catenary curve between the connection point 158 and the second connection point 160 in the closed configuration of valve 100. Similarly, the arcuate edge 180 can define opening 156 when the valve 100 is in the open configuration.
In an additional embodiment, in the open configuration the portion of the cover 104 forming the first valve leaflet 162 and the second valve leaflet 164 provides sufficient excess material spanning between the first connection point 158 and the second connection point 160 to allow the first and second major surfaces 172 and 178 to take on a semi-tubular structure 182, as shown in
Each of the second major surfaces 178 of the first valve leaflet 162 and the second valve leaflet 164 can further include a curve imparted thereto so as to provide the first major surface 172 with the concave structure. The concave structure allows the first valve leaflet 162 and the second valve leaflet 164 to better collect retrograde fluid flow to urge the first valve leaflet 162 and the second valve leaflet 164 towards the closed configuration. For example, as retrograde flow begins, the first valve leaflet 162 and the second valve leaflet 164 respond by moving towards the center (e.g., towards 118) of valve 100. As the first valve leaflet 162 and the second valve leaflet 164 approach the center of the device the sealing surfaces 176 make sufficient contact to effectively close valve 100 and restrict retrograde fluid flow.
In an additional embodiment, the first valve leaflet 162 and the second valve leaflet 164 can include one or more support structures, where the support structures can be integrated into and/or onto the valve leaflets 162 and 164. For example, the first valve leaflet 162 and the second valve leaflet 164 can include one or more support ribs, as the same will be known and understood, having a predetermined shape. In one embodiment, the predetermined shape of the support ribs can include a curved bias so as to provide the first valve leaflet 162 and the second valve leaflet 164 with a curved configuration. Support ribs can be constructed of a flexible material and have dimensions (e.g., thickness, width and length) and cross-sectional shape that allows the support ribs to be flexible when the first valve leaflet 162 and the second valve leaflet 164 are urged into an open position, and stiff when the first valve leaflet 162 and the second valve leaflet 164 are urged into a closed position upon experiencing sufficient back flow pressure from the direction downstream from the valve. In an additional embodiment, support ribs can also be attached to valve frame 102 so as to impart a spring bias to the valve leaflets in either the open or the closed configuration.
In one embodiment, the material of the first valve leaflet 162 and the second valve leaflet 164 can be sufficiently thin and pliable so as to permit radially-collapsing of the valve leaflets for delivery by catheter to a location within a body lumen. The first valve leaflet 162 and the second valve leaflet 164 can be constructed of a fluid-impermeable biocompatible material that can be either synthetic or biologic. Possible synthetic materials include, but are not limited to, expanded polytetrafluoroethylene (ePTFE), polytetrafluoroethylene (PTFE), polystyrene-polyisobutylene-polystyrene (SIBS), polyurethane, segmented poly(carbonate-urethane), Dacron, polyethlylene (PE), polyethylene terephthalate (PET), silk, urethane, Rayon, Silicone, or the like. Possible biologic materials include, but are not limited to, autologous, allogeneic or xenograft material. These include explanted veins and decellularized basement membrane materials, such as small intestine submucosa (SIS) or umbilical vein.
As discussed herein, the cover 104 can be located over at least the outer surface 152 of the frame 102. In an additional embodiment, the cover 104 can also be located over at least the inner surface 154 of the frame 102, where the cover 104 can be joined to itself in the area between the members (e.g., between first member 120 and third member 124, and second member 122 and fourth member 128) so as to fully or partially encase the frame 102. Numerous techniques may be employed to laminate or bond cover 104 on the outer surface 152 and/or the inner surface 154 of the frame 102, including heat setting, adhesive welding, application of uniform force and other bonding techniques. Additionally, the cover 104 may be folded over the first end of the frame 102 to provide the cover 104 on both the outer surface 106 and the inner surface 108. Cover 104 can also be joined to itself and/or the members according to the methods described in U.S. Patent Application Publication US 2002/0178570 to Sogard et al., which is hereby incorporated by reference in its entirety.
The cover 104 can also be coupled to the connection points so as to form the valve leaflets, as discussed herein. In one embodiment, the cover 104 can be in the form of a sheet or a sleeve of material, as discussed herein, which can be connected to the frame 102. Alternatively, the cover 104 can initially be in the form of a liquid that can be used to cast and/or form the cover over the frame 102. Other forms, including intermediate forms, of the cover 104 are also possible.
The cover 104 can be coupled to the frame 102, including the connection points 158 and 160, in a variety of ways so as to provide the various embodiments of the valve of the present invention. For example, a variety of fasteners can be used to couple the cover 104 to the frame 102 so as to form the valve 100. Suitable fasteners can include, but are not limited to, biocompatible staples, glues, sutures or combinations thereof. In an additional embodiment, the cover 104 can be coupled to the frame 102 through the use of heat sealing, solvent bonding, adhesive bonding, or welding cover 104 to either a portion of the cover 104 (i.e., itself) and/or the frame 102.
The cover 104, including the valve leaflets 162 and 164, may also be treated and/or coated with a number of surface or material treatments. For example, the cover 104 can be treated with one or more biologically active compounds and/or materials that may promote and/or inhibit endothelization and/or smooth muscle cell growth of the cover 104, including the valve leaflets 162 and 164. Similarly, the cover 104 may be seeded and covered with cultured tissue cells (e.g., endothelial cells) derived from a either a donor or the host patient which are attached to the valve leaflets 162 and 164. The cultured tissue cells may be initially positioned to extend either partially or fully over the valve leaflets 162 and 164.
Cover 104, in addition to forming valve leaflets 162 and 164, can also be capable of inhibiting thrombus formation. Additionally, cover 104 may either prevent or facilitate tissue ingrowth therethrough, as the particular application for the valve 100 may dictate. For example, cover 104 on the outer surface 152 may be formed from a porous material to facilitate tissue ingrowth therethrough, while cover 104 on the inner surface 154 may be formed from a material or a treated material which inhibits tissue ingrowth.
The system 784 can further include a deployment shaft 798 positioned within lumen 794, and a sheath 701 positioned adjacent the distal end 792. In one embodiment, the valve 700 can be positioned at least partially within the sheath 601 and adjacent the deployment shaft 798. The deployment shaft 798 can be moved within the lumen 794 to deploy valve 700. For example, deployment shaft 798 can be used to push valve 700 from sheath 701 in deploying valve 700.
The embodiments of the present invention further include methods for forming the valve of the present invention, as discussed herein. For example, the valve can be formed from the frame and the cover over at least the outer surface of the frame, where the cover includes surfaces defining the reversibly sealable opening for unidirectional flow of a liquid through the lumen. In an additional example, the valve can be reversibly joined to the catheter, which can include a process of altering the shape of the valve from a first shape, for example an expanded state, to the compressed state, as described herein.
For example, the valve can be reversibly joined with the catheter by positioning valve in the compressed state at least partially within the sheath of the catheter. In one embodiment, positioning the valve at least partially within the sheath of the catheter includes positioning the valve in the compressed state adjacent the deployment shaft of the catheter. In an another embodiment, the sheath of the catheter functions as a retractable sheath, where the valve in the compressed state can be reversibly joined with the catheter by positioning the valve at least partially within the reversible sheath of the catheter. In a further embodiment, the catheter can include an inflatable balloon, where the balloon can be positioned at least partially within the lumen of the valve, for example, in its compressed state.
The embodiments of the valve described herein may be used to replace, supplement, or augment valve structures within one or more lumens of the body. For example, embodiments of the present invention may be used to replace an incompetent venous valve and help to decrease backflow of blood in the venous system of the legs.
In one embodiment, the method of replacing, supplementing, and/or augmenting a valve structure can include positioning at least part of the catheter including the valve at a predetermined location within the lumen of a body. For example, the predetermined location can include a position within a body lumen of a venous system of a patient, such as a vein of a leg.
In one embodiment, positioning the catheter that includes the valve within the body lumen of a venous system includes introducing the catheter into the venous system of the patient using minimally invasive percutaneous, transluminal catheter based delivery system, as is known in the art. For example, a guidewire can be positioned within a body lumen of a patient that includes the predetermined location. The catheter, including valve, as described herein, can be positioned over the guidewire and the catheter advanced so as to position the valve at or adjacent the predetermined location. In one embodiment, radiopaque markers on the catheter and/or the valve, as described herein, can be used to help locate and position the valve. For example, embodiments for positioning radiopaque markers on the catheter and/or the valve can be found in co-pending U.S. patent application Ser. No. 11/150,331, filed on Jun. 10, 2005 and entitled “Venous Valve Frame, System, and Method”, which is incorporated herein by reference in its entirety.
The valve can be deployed from the catheter at the predetermined location in a number of ways, as described herein. In one embodiment, valve of the present invention can be deployed and placed in a number of vascular locations. For example, valve can be deployed and placed within a major vein of a patient's leg. In one embodiment, major veins include, but are not limited to, those of the peripheral venous system. Examples of veins in the peripheral venous system include, but are not limited to, the superficial veins such as the short saphenous vein and the greater saphenous vein, and the veins of the deep venous system, such as the popliteal vein and the femoral vein.
As discussed herein, the valve can be deployed from the catheter in a number of ways. For example, the catheter can include the retractable sheath in which valve can be at least partially housed, as discussed herein. Valve can be deployed by retracting the retractable sheath of the catheter, where the valve self-expands to be positioned at the predetermined location. In an additional example, the catheter can include a deployment shaft and sheath in which valve can be at least partially housed adjacent the deployment shaft, as discussed herein. Valve can be deployed by moving the deployment shaft through the catheter to deploy valve from the sheath, where the valve self-expands to be positioned at the predetermined location. In an additional embodiment, the valve can be deployed through the use of an inflatable balloon.
Once implanted, the valve can provide sufficient contact and expansion force against the body lumen wall to prevent retrograde flow between the valve and the body lumen wall. For example, the valve can be selected to have a larger expansion diameter than the diameter of the inner wall of the body lumen. This can then allow valve to exert a force on the body lumen wall and accommodate changes in the body lumen diameter, while maintaining the proper placement of valve. As described herein, the valve can engage the lumen so as to reduce the volume of retrograde flow through and around valve. It is, however, understood that some leaking or fluid flow may occur between the valve and the body lumen and/or through valve leaflets.
While the present invention has been shown and described in detail above, it will be clear to the person skilled in the art that changes and modifications may be made without departing from the scope of the invention. As such, that which is set forth in the foregoing description and accompanying drawings is offered by way of illustration only and not as a limitation. The actual scope of the invention is intended to be defined by the following claims, along with the full range of equivalents to which such claims are entitled.
In addition, one of ordinary skill in the art will appreciate upon reading and understanding this disclosure that other variations for the invention described herein can be included within the scope of the present invention. For example, the frame 102 and/or the cover 104 can be coated with a non-thrombogenic biocompatible material, as are known or will be known.
In the foregoing Detailed Description, various features are grouped together in several embodiments for the purpose of streamlining the disclosure. This method of disclosure is not to be interpreted as reflecting an intention that the embodiments of the invention require more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive subject matter lies in less than all features of a single disclosed embodiment. Thus, the following claims are hereby incorporated into the Detailed Description, with each claim standing on its own as a separate embodiment.
Number | Name | Date | Kind |
---|---|---|---|
3671979 | Moulopoulos | Jun 1972 | A |
4291420 | Reul | Sep 1981 | A |
4787901 | Baykut | Nov 1988 | A |
4872874 | Taheri | Oct 1989 | A |
4935030 | Alonso | Jun 1990 | A |
4994077 | Dobben | Feb 1991 | A |
5002567 | Bona et al. | Mar 1991 | A |
5141491 | Bowald | Aug 1992 | A |
5163953 | Vince | Nov 1992 | A |
5219355 | Parodi et al. | Jun 1993 | A |
5254127 | Wholey et al. | Oct 1993 | A |
5327774 | Nguyen et al. | Jul 1994 | A |
5332402 | Teitelbaum | Jul 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5411552 | Anderson et al. | May 1995 | A |
5469868 | Reger | Nov 1995 | A |
5480423 | Ravenscroft et al. | Jan 1996 | A |
5500014 | Quijano et al. | Mar 1996 | A |
5545214 | Stevens | Aug 1996 | A |
5554185 | Block et al. | Sep 1996 | A |
5643208 | Parodi | Jul 1997 | A |
5693087 | Parodi | Dec 1997 | A |
5713953 | Vallana et al. | Feb 1998 | A |
5716370 | Williamson, IV et al. | Feb 1998 | A |
5735859 | Fischell et al. | Apr 1998 | A |
5741326 | Solovay | Apr 1998 | A |
5741333 | Frid | Apr 1998 | A |
5800506 | Perouse | Sep 1998 | A |
5824061 | Quijano et al. | Oct 1998 | A |
5879320 | Cazenave | Mar 1999 | A |
5895419 | Tweden et al. | Apr 1999 | A |
5910170 | Reimink et al. | Jun 1999 | A |
6010531 | Donlon et al. | Jan 2000 | A |
6042607 | Williamson, IV et al. | Mar 2000 | A |
6139575 | Shu et al. | Oct 2000 | A |
6287334 | Moll et al. | Sep 2001 | B1 |
6312447 | Grimes | Nov 2001 | B1 |
6355030 | Aldrich et al. | Mar 2002 | B1 |
6402780 | Williamson, IV et al. | Jun 2002 | B2 |
6419696 | Ortiz et al. | Jul 2002 | B1 |
6425916 | Garrison et al. | Jul 2002 | B1 |
6440164 | DiMatteo et al. | Aug 2002 | B1 |
6451054 | Stevens | Sep 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6461366 | Seguin | Oct 2002 | B1 |
6503272 | Duerig et al. | Jan 2003 | B2 |
6508833 | Pavcnik et al. | Jan 2003 | B2 |
6564805 | Garrison et al. | May 2003 | B2 |
6569196 | Vesely | May 2003 | B1 |
6602286 | Strecker | Aug 2003 | B1 |
6629534 | St. Goar et al. | Oct 2003 | B1 |
6635085 | Caffey et al. | Oct 2003 | B1 |
6666885 | Moe | Dec 2003 | B2 |
6666886 | Tranquillo et al. | Dec 2003 | B1 |
6669725 | Scott | Dec 2003 | B2 |
6673109 | Cox | Jan 2004 | B2 |
6676698 | McGuckin, Jr. et al. | Jan 2004 | B2 |
6676702 | Mathis | Jan 2004 | B2 |
6682558 | Tu et al. | Jan 2004 | B2 |
6682559 | Myers et al. | Jan 2004 | B2 |
6685739 | DiMatteo et al. | Feb 2004 | B2 |
6692512 | Jang | Feb 2004 | B2 |
6695866 | Kuehn et al. | Feb 2004 | B1 |
6695878 | McGuckin, Jr. et al. | Feb 2004 | B2 |
6709456 | Langberg et al. | Mar 2004 | B2 |
6709457 | Otte et al. | Mar 2004 | B1 |
6716241 | Wilder et al. | Apr 2004 | B2 |
6716244 | Klaco | Apr 2004 | B2 |
6719767 | Kimblad | Apr 2004 | B1 |
6719784 | Henderson | Apr 2004 | B2 |
6719786 | Ryan et al. | Apr 2004 | B2 |
6719787 | Cox | Apr 2004 | B2 |
6719788 | Cox | Apr 2004 | B2 |
6719789 | Cox | Apr 2004 | B2 |
6719790 | Brendzel et al. | Apr 2004 | B2 |
6723038 | Schroeder et al. | Apr 2004 | B1 |
6723122 | Yang et al. | Apr 2004 | B2 |
6723123 | Kazatchkov et al. | Apr 2004 | B1 |
6726715 | Sutherland | Apr 2004 | B2 |
6726716 | Marquez | Apr 2004 | B2 |
6726717 | Alfieri et al. | Apr 2004 | B2 |
6730118 | Spenser et al. | May 2004 | B2 |
6730121 | Ortiz et al. | May 2004 | B2 |
6730122 | Pan et al. | May 2004 | B1 |
6736845 | Marquez et al. | May 2004 | B2 |
6736846 | Cox | May 2004 | B2 |
6749630 | McCarthy et al. | Jun 2004 | B2 |
6752813 | Goldfarb et al. | Jun 2004 | B2 |
6752828 | Thornton | Jun 2004 | B2 |
6755857 | Peterson et al. | Jun 2004 | B2 |
6761734 | Suhr | Jul 2004 | B2 |
6761735 | Eberhardt et al. | Jul 2004 | B2 |
6764494 | Menz et al. | Jul 2004 | B2 |
6764508 | Roehe et al. | Jul 2004 | B1 |
6764509 | Chinn et al. | Jul 2004 | B2 |
6764510 | Vidlund et al. | Jul 2004 | B2 |
6767362 | Schreck | Jul 2004 | B2 |
6769434 | Liddicoat et al. | Aug 2004 | B2 |
6770083 | Seguin | Aug 2004 | B2 |
6780200 | Jansen | Aug 2004 | B2 |
6786924 | Ryan et al. | Sep 2004 | B2 |
6786925 | Schoon et al. | Sep 2004 | B1 |
6790229 | Berreklouw | Sep 2004 | B1 |
6790230 | Beyersdorf et al. | Sep 2004 | B2 |
6790231 | Liddicoat et al. | Sep 2004 | B2 |
6793673 | Kowalsky et al. | Sep 2004 | B2 |
6797000 | Simpson et al. | Sep 2004 | B2 |
6797001 | Mathis et al. | Sep 2004 | B2 |
6797002 | Spence et al. | Sep 2004 | B2 |
6802860 | Cosgrove et al. | Oct 2004 | B2 |
6805710 | Bolling et al. | Oct 2004 | B2 |
6805711 | Quijano et al. | Oct 2004 | B2 |
6810882 | Langberg et al. | Nov 2004 | B2 |
6821297 | Snyders | Nov 2004 | B2 |
6824562 | Mathis et al. | Nov 2004 | B2 |
6830584 | Seguin | Dec 2004 | B1 |
6830585 | Artof et al. | Dec 2004 | B1 |
6837902 | Nguyen et al. | Jan 2005 | B2 |
6840246 | Downing | Jan 2005 | B2 |
6840957 | DiMatteo et al. | Jan 2005 | B2 |
6846324 | Stobie | Jan 2005 | B2 |
6846325 | Liddicoat | Jan 2005 | B2 |
6858039 | McCarthy | Feb 2005 | B2 |
6869444 | Gabbay | Mar 2005 | B2 |
6872226 | Cali et al. | Mar 2005 | B2 |
6875224 | Grimes | Apr 2005 | B2 |
6875230 | Morita et al. | Apr 2005 | B1 |
6875231 | Anduiza et al. | Apr 2005 | B2 |
6881199 | Wilk et al. | Apr 2005 | B2 |
6881224 | Kruse et al. | Apr 2005 | B2 |
6883522 | Spence et al. | Apr 2005 | B2 |
6890352 | Lentell | May 2005 | B1 |
6890353 | Cohn et al. | May 2005 | B2 |
6893459 | Macoviak | May 2005 | B1 |
6893460 | Spenser et al. | May 2005 | B2 |
6896700 | Lu et al. | May 2005 | B2 |
6902576 | Drasler et al. | Jun 2005 | B2 |
6908478 | Alferness et al. | Jun 2005 | B2 |
6908481 | Cribier | Jun 2005 | B2 |
6911043 | Myers et al. | Jun 2005 | B2 |
6913608 | Liddicoat et al. | Jul 2005 | B2 |
6916338 | Speziali | Jul 2005 | B2 |
6918917 | Nguyen et al. | Jul 2005 | B1 |
6921407 | Nguyen et al. | Jul 2005 | B2 |
6921811 | Zamora et al. | Jul 2005 | B2 |
6926715 | Hauck et al. | Aug 2005 | B1 |
6926730 | Nguyen et al. | Aug 2005 | B1 |
6929653 | Strecter | Aug 2005 | B2 |
6932838 | Schwartz et al. | Aug 2005 | B2 |
6936067 | Buchanan | Aug 2005 | B2 |
6939359 | Tu et al. | Sep 2005 | B2 |
6942694 | Liddicoat et al. | Sep 2005 | B2 |
6945957 | Freyman | Sep 2005 | B2 |
6945978 | Hyde | Sep 2005 | B1 |
6945996 | Sedransk | Sep 2005 | B2 |
6945997 | Huynh et al. | Sep 2005 | B2 |
6949122 | Adams et al. | Sep 2005 | B2 |
6951571 | Srivastava | Oct 2005 | B1 |
6951573 | Dilling | Oct 2005 | B1 |
6953332 | Kurk et al. | Oct 2005 | B1 |
6955689 | Ryan et al. | Oct 2005 | B2 |
6958076 | Acosta et al. | Oct 2005 | B2 |
6962605 | Cosgrove et al. | Nov 2005 | B2 |
6964682 | Nguyen-Thien-Nhon et al. | Nov 2005 | B2 |
6964683 | Kowalsky et al. | Nov 2005 | B2 |
6964684 | Ortiz et al. | Nov 2005 | B2 |
6966925 | Stobie | Nov 2005 | B2 |
6966926 | Mathis | Nov 2005 | B2 |
6974464 | Quijano et al. | Dec 2005 | B2 |
6974474 | Pavcnik et al. | Dec 2005 | B2 |
6974476 | McGuckin, Jr. et al. | Dec 2005 | B2 |
6976995 | Mathis et al. | Dec 2005 | B2 |
6979350 | Moll et al. | Dec 2005 | B2 |
6986775 | Morales et al. | Jan 2006 | B2 |
6989027 | Allen et al. | Jan 2006 | B2 |
6989028 | Lashinski et al. | Jan 2006 | B2 |
6997950 | Chawla | Feb 2006 | B2 |
6997951 | Solem et al. | Feb 2006 | B2 |
7004176 | Lau | Feb 2006 | B2 |
7007396 | Rudko et al. | Mar 2006 | B2 |
7011669 | Kimblad | Mar 2006 | B2 |
7011681 | Vesely | Mar 2006 | B2 |
7011682 | Lahsinski et al. | Mar 2006 | B2 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7018407 | Wright et al. | Mar 2006 | B1 |
7018408 | Bailey et al. | Mar 2006 | B2 |
7022134 | Quijano et al. | Apr 2006 | B1 |
7025780 | Gabbay | Apr 2006 | B2 |
7033390 | Johnson et al. | Apr 2006 | B2 |
7037333 | Myers et al. | May 2006 | B2 |
7037334 | Hlavka et al. | May 2006 | B1 |
7041128 | McGuckin, Jr. et al. | May 2006 | B2 |
7041132 | Quijano et al. | May 2006 | B2 |
7044966 | Svanidze et al. | May 2006 | B2 |
7044967 | Solem et al. | May 2006 | B1 |
7048754 | Martin et al. | May 2006 | B2 |
7048757 | Shaknovich | May 2006 | B2 |
7052487 | Cohn et al. | May 2006 | B2 |
7052507 | Wakuda et al. | May 2006 | B2 |
7063722 | Marquez | Jun 2006 | B2 |
7066954 | Ryan et al. | Jun 2006 | B2 |
7070616 | Majercak et al. | Jul 2006 | B2 |
7070618 | Streeter | Jul 2006 | B2 |
7077862 | Vidlund et al. | Jul 2006 | B2 |
7081131 | Thornton | Jul 2006 | B2 |
7087064 | Hyde | Aug 2006 | B1 |
7089051 | Jäverud et al. | Aug 2006 | B2 |
7090695 | Solem et al. | Aug 2006 | B2 |
20020013571 | Goldfarb et al. | Jan 2002 | A1 |
20020026216 | Grimes | Feb 2002 | A1 |
20020082630 | Menz et al. | Jun 2002 | A1 |
20020099439 | Schwartz et al. | Jul 2002 | A1 |
20020123802 | Snyders | Sep 2002 | A1 |
20020151970 | Garrison et al. | Oct 2002 | A1 |
20020183835 | Taylor et al. | Dec 2002 | A1 |
20020183838 | Liddicoat et al. | Dec 2002 | A1 |
20020198594 | Schreck | Dec 2002 | A1 |
20030050694 | Yang et al. | Mar 2003 | A1 |
20030130729 | Paniagua et al. | Jul 2003 | A1 |
20030163194 | Quijano et al. | Aug 2003 | A1 |
20030167071 | Martin et al. | Sep 2003 | A1 |
20030171806 | Mathis et al. | Sep 2003 | A1 |
20030199975 | Gabbay | Oct 2003 | A1 |
20030229394 | Ogle et al. | Dec 2003 | A1 |
20030229395 | Cox | Dec 2003 | A1 |
20030233142 | Morales et al. | Dec 2003 | A1 |
20030236568 | Hojeibane et al. | Dec 2003 | A1 |
20030236569 | Mathis et al. | Dec 2003 | A1 |
20040002719 | Oz et al. | Jan 2004 | A1 |
20040003819 | St. Goar et al. | Jan 2004 | A1 |
20040010305 | Alferness et al. | Jan 2004 | A1 |
20040015230 | Moll et al. | Jan 2004 | A1 |
20040015232 | Shu et al. | Jan 2004 | A1 |
20040015233 | Jansen | Jan 2004 | A1 |
20040019374 | Hojeibane et al. | Jan 2004 | A1 |
20040019377 | Taylor et al. | Jan 2004 | A1 |
20040019378 | Hlavka et al. | Jan 2004 | A1 |
20040024447 | Haverich | Feb 2004 | A1 |
20040024451 | Johnson et al. | Feb 2004 | A1 |
20040024452 | Kruse et al. | Feb 2004 | A1 |
20040030321 | Fangrow, Jr. | Feb 2004 | A1 |
20040030381 | Shu | Feb 2004 | A1 |
20040030382 | St. Goar et al. | Feb 2004 | A1 |
20040030405 | Carpentier et al. | Feb 2004 | A1 |
20040034380 | Woolfson et al. | Feb 2004 | A1 |
20040034411 | Quijano et al. | Feb 2004 | A1 |
20040039436 | Spenser et al. | Feb 2004 | A1 |
20040039442 | St. Goar et al. | Feb 2004 | A1 |
20040039443 | Solem et al. | Feb 2004 | A1 |
20040044350 | Martin et al. | Mar 2004 | A1 |
20040044365 | Bachman | Mar 2004 | A1 |
20040044403 | Bischoff et al. | Mar 2004 | A1 |
20040049207 | Goldfarb et al. | Mar 2004 | A1 |
20040049211 | Tremulis et al. | Mar 2004 | A1 |
20040049266 | Anduiza et al. | Mar 2004 | A1 |
20040059351 | Eigler et al. | Mar 2004 | A1 |
20040059411 | Strecker | Mar 2004 | A1 |
20040059412 | Lytle, IV et al. | Mar 2004 | A1 |
20040060161 | Leal et al. | Apr 2004 | A1 |
20040073301 | Donlon et al. | Apr 2004 | A1 |
20040073302 | Rourke et al. | Apr 2004 | A1 |
20040078072 | Tu et al. | Apr 2004 | A1 |
20040078074 | Anderson et al. | Apr 2004 | A1 |
20040082910 | Constantz et al. | Apr 2004 | A1 |
20040082923 | Field | Apr 2004 | A1 |
20040082991 | Nguyen et al. | Apr 2004 | A1 |
20040087975 | Lucatero et al. | May 2004 | A1 |
20040088045 | Cox | May 2004 | A1 |
20040088046 | Speziali | May 2004 | A1 |
20040092858 | Wilson et al. | May 2004 | A1 |
20040093060 | Seguin et al. | May 2004 | A1 |
20040093070 | Hojeibane et al. | May 2004 | A1 |
20040093080 | Helmus et al. | May 2004 | A1 |
20040097979 | Svanidze et al. | May 2004 | A1 |
20040098098 | McGuckin, Jr. et al. | May 2004 | A1 |
20040098112 | DiMatteo et al. | May 2004 | A1 |
20040102839 | Cohn et al. | May 2004 | A1 |
20040102840 | Solem et al. | May 2004 | A1 |
20040102842 | Jansen | May 2004 | A1 |
20040106976 | Bailey et al. | Jun 2004 | A1 |
20040106990 | Spence et al. | Jun 2004 | A1 |
20040106991 | Hopkins et al. | Jun 2004 | A1 |
20040111096 | Tu et al. | Jun 2004 | A1 |
20040117009 | Cali et al. | Jun 2004 | A1 |
20040122448 | Levine | Jun 2004 | A1 |
20040122512 | Navia et al. | Jun 2004 | A1 |
20040122513 | Navia et al. | Jun 2004 | A1 |
20040122514 | Fogarty et al. | Jun 2004 | A1 |
20040122515 | Chu | Jun 2004 | A1 |
20040122516 | Fogarty et al. | Jun 2004 | A1 |
20040127979 | Wilson et al. | Jul 2004 | A1 |
20040127980 | Kowalsky et al. | Jul 2004 | A1 |
20040127981 | Rahdert et al. | Jul 2004 | A1 |
20040127982 | Machold et al. | Jul 2004 | A1 |
20040133220 | Lashinski et al. | Jul 2004 | A1 |
20040133267 | Lane | Jul 2004 | A1 |
20040133273 | Cox | Jul 2004 | A1 |
20040138742 | Myers et al. | Jul 2004 | A1 |
20040138743 | Myers et al. | Jul 2004 | A1 |
20040138744 | Lashinski et al. | Jul 2004 | A1 |
20040138745 | Macoviak et al. | Jul 2004 | A1 |
20040148018 | Carpentier et al. | Jul 2004 | A1 |
20040148019 | Vidlund et al. | Jul 2004 | A1 |
20040148020 | Vidlund et al. | Jul 2004 | A1 |
20040153052 | Mathis | Aug 2004 | A1 |
20040153146 | Lashinski et al. | Aug 2004 | A1 |
20040153147 | Mathis | Aug 2004 | A1 |
20040158321 | Reuter et al. | Aug 2004 | A1 |
20040162610 | Liska et al. | Aug 2004 | A1 |
20040167539 | Keuhn et al. | Aug 2004 | A1 |
20040167620 | Ortiz et al. | Aug 2004 | A1 |
20040172046 | Hlavka et al. | Sep 2004 | A1 |
20040176839 | Huynh et al. | Sep 2004 | A1 |
20040176840 | Langberg et al. | Sep 2004 | A1 |
20040181238 | Zarbatany et al. | Sep 2004 | A1 |
20040186444 | Daly et al. | Sep 2004 | A1 |
20040186558 | Pavcnik et al. | Sep 2004 | A1 |
20040186561 | McGuckin, Jr. et al. | Sep 2004 | A1 |
20040186563 | Lobbi | Sep 2004 | A1 |
20040186565 | Schreck | Sep 2004 | A1 |
20040186566 | Hindrichs et al. | Sep 2004 | A1 |
20040193191 | Starksen et al. | Sep 2004 | A1 |
20040193253 | Thorpe et al. | Sep 2004 | A1 |
20040193260 | Alferness et al. | Sep 2004 | A1 |
20040199155 | Mollenauer | Oct 2004 | A1 |
20040199183 | Oz et al. | Oct 2004 | A1 |
20040199191 | Schwartz | Oct 2004 | A1 |
20040204758 | Eberhardt et al. | Oct 2004 | A1 |
20040206363 | McCarthy et al. | Oct 2004 | A1 |
20040210240 | Saint | Oct 2004 | A1 |
20040210301 | Obermiller | Oct 2004 | A1 |
20040210303 | Sedransk | Oct 2004 | A1 |
20040210304 | Seguin et al. | Oct 2004 | A1 |
20040210305 | Shu et al. | Oct 2004 | A1 |
20040210306 | Quijano et al. | Oct 2004 | A1 |
20040210307 | Khairkhahan | Oct 2004 | A1 |
20040215333 | Duran et al. | Oct 2004 | A1 |
20040215339 | Drasler et al. | Oct 2004 | A1 |
20040220654 | Mathis et al. | Nov 2004 | A1 |
20040220657 | Nieminen et al. | Nov 2004 | A1 |
20040225322 | Garrison et al. | Nov 2004 | A1 |
20040225344 | Hoffa et al. | Nov 2004 | A1 |
20040225348 | Case et al. | Nov 2004 | A1 |
20040225352 | Osborne et al. | Nov 2004 | A1 |
20040225353 | McGuckin, Jr. et al. | Nov 2004 | A1 |
20040225354 | Allen et al. | Nov 2004 | A1 |
20040225355 | Stevens | Nov 2004 | A1 |
20040225356 | Frater | Nov 2004 | A1 |
20040230117 | Tosaya et al. | Nov 2004 | A1 |
20040230297 | Thornton | Nov 2004 | A1 |
20040236411 | Sarac et al. | Nov 2004 | A1 |
20040236418 | Stevens | Nov 2004 | A1 |
20040236419 | Milo | Nov 2004 | A1 |
20040243153 | Liddicoat et al. | Dec 2004 | A1 |
20040243219 | Fischer et al. | Dec 2004 | A1 |
20040243227 | Starksen et al. | Dec 2004 | A1 |
20040243228 | Kowalsky et al. | Dec 2004 | A1 |
20040243230 | Navia et al. | Dec 2004 | A1 |
20040249452 | Adams et al. | Dec 2004 | A1 |
20040254600 | Zarbatany et al. | Dec 2004 | A1 |
20040254636 | Flagle et al. | Dec 2004 | A1 |
20040260276 | Rudko et al. | Dec 2004 | A1 |
20040260317 | Bloom et al. | Dec 2004 | A1 |
20040260322 | Rudko et al. | Dec 2004 | A1 |
20040260389 | Case et al. | Dec 2004 | A1 |
20040260390 | Sarac et al. | Dec 2004 | A1 |
20040260393 | Rahdert et al. | Dec 2004 | A1 |
20040260394 | Douk et al. | Dec 2004 | A1 |
20040267357 | Allen et al. | Dec 2004 | A1 |
20050004583 | Oz et al. | Jan 2005 | A1 |
20050004667 | Swinford et al. | Jan 2005 | A1 |
20050010285 | Lambrecht et al. | Jan 2005 | A1 |
20050010287 | Macoviak et al. | Jan 2005 | A1 |
20050015112 | Cohn et al. | Jan 2005 | A1 |
20050021056 | St. Goar et al. | Jan 2005 | A1 |
20050021136 | Xie et al. | Jan 2005 | A1 |
20050027261 | Weaver et al. | Feb 2005 | A1 |
20050027348 | Case et al. | Feb 2005 | A1 |
20050027351 | Reuter et al. | Feb 2005 | A1 |
20050027353 | Alferness et al. | Feb 2005 | A1 |
20050033398 | Seguin | Feb 2005 | A1 |
20050033419 | Alferness et al. | Feb 2005 | A1 |
20050033446 | Deem et al. | Feb 2005 | A1 |
20050038506 | Webler et al. | Feb 2005 | A1 |
20050038507 | Alferness et al. | Feb 2005 | A1 |
20050043790 | Seguin | Feb 2005 | A1 |
20050043792 | Solem et al. | Feb 2005 | A1 |
20050049679 | Taylor et al. | Mar 2005 | A1 |
20050049692 | Numamoto et al. | Mar 2005 | A1 |
20050049696 | Siess et al. | Mar 2005 | A1 |
20050049697 | Sievers | Mar 2005 | A1 |
20050054977 | Laird et al. | Mar 2005 | A1 |
20050055079 | Duran | Mar 2005 | A1 |
20050055087 | Starksen | Mar 2005 | A1 |
20050055088 | Liddicoat et al. | Mar 2005 | A1 |
20050055089 | Macoviak et al. | Mar 2005 | A1 |
20050060029 | Le et al. | Mar 2005 | A1 |
20050060030 | Lashinski et al. | Mar 2005 | A1 |
20050065460 | Laird | Mar 2005 | A1 |
20050065550 | Starksen et al. | Mar 2005 | A1 |
20050065594 | Dimatteo et al. | Mar 2005 | A1 |
20050065597 | Lansac | Mar 2005 | A1 |
20050070998 | Rourke et al. | Mar 2005 | A1 |
20050075584 | Cali | Apr 2005 | A1 |
20050075659 | Realyvasquez et al. | Apr 2005 | A1 |
20050075662 | Pedersen et al. | Apr 2005 | A1 |
20050075712 | Biancucci et al. | Apr 2005 | A1 |
20050075713 | Biancucci et al. | Apr 2005 | A1 |
20050075717 | Nguyen et al. | Apr 2005 | A1 |
20050075718 | Nguyen et al. | Apr 2005 | A1 |
20050075719 | Bergheim | Apr 2005 | A1 |
20050075720 | Nguyen et al. | Apr 2005 | A1 |
20050075723 | Schroeder et al. | Apr 2005 | A1 |
20050075724 | Svanidze et al. | Apr 2005 | A1 |
20050075725 | Rowe | Apr 2005 | A1 |
20050075726 | Svanidze et al. | Apr 2005 | A1 |
20050075728 | Nguyen et al. | Apr 2005 | A1 |
20050075729 | Nguyen et al. | Apr 2005 | A1 |
20050075730 | Myers et al. | Apr 2005 | A1 |
20050075731 | Artof et al. | Apr 2005 | A1 |
20050080483 | Solem et al. | Apr 2005 | A1 |
20050085900 | Case et al. | Apr 2005 | A1 |
20050085903 | Lau | Apr 2005 | A1 |
20050085904 | Lemmon | Apr 2005 | A1 |
20050090846 | Pedersen et al. | Apr 2005 | A1 |
20050096735 | Hojeibane et al. | May 2005 | A1 |
20050096738 | Cali et al. | May 2005 | A1 |
20050096739 | Cao | May 2005 | A1 |
20050096740 | Langberg et al. | May 2005 | A1 |
20050101975 | Nguyen et al. | May 2005 | A1 |
20050102026 | Turner et al. | May 2005 | A1 |
20050107810 | Morales et al. | May 2005 | A1 |
20050107811 | Starksen et al. | May 2005 | A1 |
20050107812 | Starksen et al. | May 2005 | A1 |
20050107872 | Mensah et al. | May 2005 | A1 |
20050113910 | Paniagua et al. | May 2005 | A1 |
20050119673 | Gordon et al. | Jun 2005 | A1 |
20050119734 | Spence et al. | Jun 2005 | A1 |
20050119735 | Spence et al. | Jun 2005 | A1 |
20050125011 | Spence et al. | Jun 2005 | A1 |
20050131438 | Cohn | Jun 2005 | A1 |
20050137449 | Nieminen et al. | Jun 2005 | A1 |
20050137450 | Aronson et al. | Jun 2005 | A1 |
20050137451 | Gordon et al. | Jun 2005 | A1 |
20050137676 | Richardson et al. | Jun 2005 | A1 |
20050137681 | Shoemaker et al. | Jun 2005 | A1 |
20050137682 | Justino | Jun 2005 | A1 |
20050137685 | Nieminen et al. | Jun 2005 | A1 |
20050137686 | Salahieh et al. | Jun 2005 | A1 |
20050137688 | Salahieh et al. | Jun 2005 | A1 |
20050137689 | Salahieh et al. | Jun 2005 | A1 |
20050137690 | Salahieh et al. | Jun 2005 | A1 |
20050137691 | Salahieh et al. | Jun 2005 | A1 |
20050137692 | Haug et al. | Jun 2005 | A1 |
20050137693 | Haug et al. | Jun 2005 | A1 |
20050137694 | Haug et al. | Jun 2005 | A1 |
20050137696 | Salahieh et al. | Jun 2005 | A1 |
20050137697 | Salahieh et al. | Jun 2005 | A1 |
20050137698 | Salahieh et al. | Jun 2005 | A1 |
20050137699 | Salahieh et al. | Jun 2005 | A1 |
20050137700 | Spence et al. | Jun 2005 | A1 |
20050137701 | Salahieh et al. | Jun 2005 | A1 |
20050137702 | Haug et al. | Jun 2005 | A1 |
20050143807 | Pavcnik et al. | Jun 2005 | A1 |
20050143809 | Salahieh et al. | Jun 2005 | A1 |
20050143810 | Dauner et al. | Jun 2005 | A1 |
20050143811 | Realyvasquez | Jun 2005 | A1 |
20050149014 | Hauck et al. | Jul 2005 | A1 |
20050149179 | Mathis et al. | Jul 2005 | A1 |
20050149180 | Mathis et al. | Jul 2005 | A1 |
20050149181 | Eberhardt | Jul 2005 | A1 |
20050159810 | Filsoufi | Jul 2005 | A1 |
20050159811 | Lane | Jul 2005 | A1 |
20050165477 | Anduiza et al. | Jul 2005 | A1 |
20050165478 | Song | Jul 2005 | A1 |
20050171472 | Lutter | Aug 2005 | A1 |
20050171601 | Cosgrove et al. | Aug 2005 | A1 |
20050177227 | Heim et al. | Aug 2005 | A1 |
20050177228 | Solem et al. | Aug 2005 | A1 |
20050182483 | Osborne et al. | Aug 2005 | A1 |
20050184122 | Hlavka et al. | Aug 2005 | A1 |
20050187614 | Agnew | Aug 2005 | A1 |
20050187616 | Realyvasquez | Aug 2005 | A1 |
20050187617 | Navia | Aug 2005 | A1 |
20050192606 | Paul, Jr. et al. | Sep 2005 | A1 |
20050192665 | Spenser et al. | Sep 2005 | A1 |
20050197692 | Pai et al. | Sep 2005 | A1 |
20050197693 | Pai et al. | Sep 2005 | A1 |
20050197694 | Pai et al. | Sep 2005 | A1 |
20050203549 | Realyvasquez | Sep 2005 | A1 |
20050203605 | Dolan | Sep 2005 | A1 |
20050203614 | Forster et al. | Sep 2005 | A1 |
20050203615 | Forster et al. | Sep 2005 | A1 |
20050203616 | Cribier | Sep 2005 | A1 |
20050203617 | Forster et al. | Sep 2005 | A1 |
20050203618 | Sharkawy et al. | Sep 2005 | A1 |
20050216039 | Lederman | Sep 2005 | A1 |
20050216077 | Mathis et al. | Sep 2005 | A1 |
20050216078 | Starksen et al. | Sep 2005 | A1 |
20050222675 | Sauter | Oct 2005 | A1 |
20050222678 | Lashinski et al. | Oct 2005 | A1 |
20050228422 | Machold et al. | Oct 2005 | A1 |
20050228479 | Pavcnik et al. | Oct 2005 | A1 |
20050228486 | Case et al. | Oct 2005 | A1 |
20050228494 | Marquez | Oct 2005 | A1 |
20050228495 | Macoviak | Oct 2005 | A1 |
20050228496 | Mensah et al. | Oct 2005 | A1 |
20050234541 | Hunt et al. | Oct 2005 | A1 |
20050234546 | Nugent et al. | Oct 2005 | A1 |
20050240200 | Bergheim | Oct 2005 | A1 |
20050240202 | Shennib et al. | Oct 2005 | A1 |
20050240255 | Schaeffer | Oct 2005 | A1 |
20050240259 | Sisken et al. | Oct 2005 | A1 |
20050240262 | White | Oct 2005 | A1 |
20050244460 | Alferiev et al. | Nov 2005 | A1 |
20050246013 | Gabbay | Nov 2005 | A1 |
20050251251 | Cribier | Nov 2005 | A1 |
20050256566 | Gabbay | Nov 2005 | A1 |
20050261704 | Mathis | Nov 2005 | A1 |
20050261759 | Lambrecht et al. | Nov 2005 | A1 |
20050267493 | Schreck et al. | Dec 2005 | A1 |
20050267560 | Bates | Dec 2005 | A1 |
20050267565 | Dave et al. | Dec 2005 | A1 |
20050267571 | Spence et al. | Dec 2005 | A1 |
20050267573 | Macoviak et al. | Dec 2005 | A9 |
20050267574 | Cohn et al. | Dec 2005 | A1 |
20050272969 | Alferness et al. | Dec 2005 | A1 |
20050273160 | Lashinski et al. | Dec 2005 | A1 |
20050278015 | Dave et al. | Dec 2005 | A1 |
20050283178 | Flagle et al. | Dec 2005 | A1 |
20050288779 | Shaoulian et al. | Dec 2005 | A1 |
20060000715 | Whitcher et al. | Jan 2006 | A1 |
20060004439 | Spenser et al. | Jan 2006 | A1 |
20060004442 | Spenser et al. | Jan 2006 | A1 |
20060009804 | Pederson | Jan 2006 | A1 |
20060009841 | McGuckin, Jr. et al. | Jan 2006 | A1 |
20060009842 | Huynh et al. | Jan 2006 | A1 |
20060013805 | Hebbel et al. | Jan 2006 | A1 |
20060013855 | Carpenter et al. | Jan 2006 | A1 |
20060015136 | Besselink | Jan 2006 | A1 |
20060015178 | Moaddeb et al. | Jan 2006 | A1 |
20060015179 | Bulman-Fleming et al. | Jan 2006 | A1 |
20060020275 | Goldfarb et al. | Jan 2006 | A1 |
20060020327 | Lashinski et al. | Jan 2006 | A1 |
20060020332 | Lashinski et al. | Jan 2006 | A1 |
20060020334 | Lashinski et al. | Jan 2006 | A1 |
20060020335 | Kowalsky et al. | Jan 2006 | A1 |
20060020336 | Liddicoat | Jan 2006 | A1 |
20060025750 | Startksen et al. | Feb 2006 | A1 |
20060025784 | Startksen et al. | Feb 2006 | A1 |
20060025787 | Morales et al. | Feb 2006 | A1 |
20060025854 | Lashinski et al. | Feb 2006 | A1 |
20060025855 | Lashinski et al. | Feb 2006 | A1 |
20060025856 | Ryan et al. | Feb 2006 | A1 |
20060025857 | Bergheim et al. | Feb 2006 | A1 |
20060030747 | Kantrowitz et al. | Feb 2006 | A1 |
20060030866 | Schreck | Feb 2006 | A1 |
20060030882 | Adams et al. | Feb 2006 | A1 |
20060030885 | Hyde | Feb 2006 | A1 |
20060036317 | Vidlund et al. | Feb 2006 | A1 |
20060041305 | Lauterjung | Feb 2006 | A1 |
20060041306 | Vidlund et al. | Feb 2006 | A1 |
20060047297 | Case | Mar 2006 | A1 |
20060047338 | Jenson | Mar 2006 | A1 |
20060047343 | Oviatt et al. | Mar 2006 | A1 |
20060052804 | Mialhe | Mar 2006 | A1 |
20060052867 | Revuelta et al. | Mar 2006 | A1 |
20060058817 | Starksen et al. | Mar 2006 | A1 |
20060058865 | Case et al. | Mar 2006 | A1 |
20060058871 | Zakay et al. | Mar 2006 | A1 |
20060058889 | Case et al. | Mar 2006 | A1 |
20060064115 | Allen et al. | Mar 2006 | A1 |
20060064116 | Allen et al. | Mar 2006 | A1 |
20060064118 | Kimblad | Mar 2006 | A1 |
20060064174 | Zadno | Mar 2006 | A1 |
20060069400 | Burnett et al. | Mar 2006 | A1 |
20060069429 | Spence et al. | Mar 2006 | A1 |
20060069430 | Rahdert et al. | Mar 2006 | A9 |
20060074483 | Schrayer | Apr 2006 | A1 |
20060074484 | Huber | Apr 2006 | A1 |
20060074485 | Realyvasquez | Apr 2006 | A1 |
20060085060 | Campbell | Apr 2006 | A1 |
20060089708 | Osse et al. | Apr 2006 | A1 |
20060095115 | Bladillah et al. | May 2006 | A1 |
20060095125 | Chinn et al. | May 2006 | A1 |
20060099326 | Keogh et al. | May 2006 | A1 |
20060100697 | Casanova | May 2006 | A1 |
20060100699 | Vidlund et al. | May 2006 | A1 |
20060106278 | Machold et al. | May 2006 | A1 |
20060106279 | Machold et al. | May 2006 | A1 |
20060106456 | Machold et al. | May 2006 | A9 |
20060111660 | Wolf et al. | May 2006 | A1 |
20060111773 | Rittgers et al. | May 2006 | A1 |
20060111774 | Samkov et al. | May 2006 | A1 |
20060116572 | Case | Jun 2006 | A1 |
20060116756 | Solem et al. | Jun 2006 | A1 |
20060122686 | Gilad et al. | Jun 2006 | A1 |
20060122692 | Gilad et al. | Jun 2006 | A1 |
20060122693 | Biadillah et al. | Jun 2006 | A1 |
20060127443 | Helmus | Jun 2006 | A1 |
20060129235 | Seguin et al. | Jun 2006 | A1 |
20060129236 | McCarthy | Jun 2006 | A1 |
20060135476 | Kutryk et al. | Jun 2006 | A1 |
20060135964 | Vesely | Jun 2006 | A1 |
20060135967 | Realyvasquez | Jun 2006 | A1 |
20060136044 | Osborne | Jun 2006 | A1 |
20060136045 | Flagle et al. | Jun 2006 | A1 |
20060136052 | Vesely | Jun 2006 | A1 |
20060136054 | Berg et al. | Jun 2006 | A1 |
20060142846 | Pavcnik et al. | Jun 2006 | A1 |
20060142847 | Shaknovich | Jun 2006 | A1 |
20060142848 | Gabbay | Jun 2006 | A1 |
20060142854 | Alferness et al. | Jun 2006 | A1 |
20060149358 | Zilla et al. | Jul 2006 | A1 |
20060149360 | Schwammenthal et al. | Jul 2006 | A1 |
20060149367 | Sieracki | Jul 2006 | A1 |
20060149368 | Spence | Jul 2006 | A1 |
20060161133 | Laird et al. | Jul 2006 | A1 |
20060161248 | Case et al. | Jul 2006 | A1 |
20060161249 | Realyvasquez et al. | Jul 2006 | A1 |
20060161250 | Shaw | Jul 2006 | A1 |
20060167468 | Gabbay | Jul 2006 | A1 |
20060167541 | Lattouf | Jul 2006 | A1 |
20060167542 | Quintessenza | Jul 2006 | A1 |
20060167543 | Bailey et al. | Jul 2006 | A1 |
20070191928 | Rolando et al. | Aug 2007 | A1 |
Number | Date | Country |
---|---|---|
0 380 666 | Aug 1990 | EP |
0 466 518 | Jan 1992 | EP |
2 728 457 | Jun 1996 | FR |
WO 8800459 | Jan 1988 | WO |
WO 9015582 | Dec 1990 | WO |
WO 9501669 | Jan 1995 | WO |
WO 9619159 | Jun 1996 | WO |
WO 9803656 | Jan 1998 | WO |
WO 9846115 | Oct 1998 | WO |
WO 9904724 | Feb 1999 | WO |
WO 0067679 | Nov 2000 | WO |
WO 0115650 | Mar 2001 | WO |
WO 0117462 | Mar 2001 | WO |
WO 03047468 | Jun 2003 | WO |
WO 03084443 | Oct 2003 | WO |
WO 2004019825 | Mar 2004 | WO |
WO 2004021893 | Mar 2004 | WO |
WO 2004023980 | Mar 2004 | WO |
WO 2004030568 | Apr 2004 | WO |
WO 2004030569 | Apr 2004 | WO |
WO 2004030570 | Apr 2004 | WO |
WO 2004032724 | Apr 2004 | WO |
WO 2004032796 | Apr 2004 | WO |
WO 2004037128 | May 2004 | WO |
WO 2004037317 | May 2004 | WO |
WO 2004039432 | May 2004 | WO |
WO 2004043265 | May 2004 | WO |
WO 2004043273 | May 2004 | WO |
WO 2004043293 | May 2004 | WO |
WO 2004045370 | Jun 2004 | WO |
WO 2004045378 | Jun 2004 | WO |
WO 2004045463 | Jun 2004 | WO |
WO 2004047677 | Jun 2004 | WO |
WO 2004060217 | Jul 2004 | WO |
WO 2004060470 | Jul 2004 | WO |
WO 2004062725 | Jul 2004 | WO |
WO 2004066803 | Aug 2004 | WO |
WO 2004066826 | Aug 2004 | WO |
WO 2004069287 | Aug 2004 | WO |
WO 2004075789 | Sep 2004 | WO |
WO 2004080352 | Sep 2004 | WO |
WO 2004082523 | Sep 2004 | WO |
WO 2004082527 | Sep 2004 | WO |
WO 2004082528 | Sep 2004 | WO |
WO 2004082536 | Sep 2004 | WO |
WO 2004082537 | Sep 2004 | WO |
WO 2004082538 | Sep 2004 | WO |
WO 2004082757 | Sep 2004 | WO |
WO 2004084746 | Oct 2004 | WO |
WO 2004084770 | Oct 2004 | WO |
WO 2004089246 | Oct 2004 | WO |
WO 2004089250 | Oct 2004 | WO |
WO 2004089253 | Oct 2004 | WO |
WO 2004091449 | Oct 2004 | WO |
WO 2004091454 | Oct 2004 | WO |
WO 2004093638 | Nov 2004 | WO |
WO 2004093726 | Nov 2004 | WO |
WO 2004093728 | Nov 2004 | WO |
WO 2004093730 | Nov 2004 | WO |
WO 2004093745 | Nov 2004 | WO |
WO 2004093935 | Nov 2004 | WO |
WO 2004096100 | Nov 2004 | WO |
WO 2004103222 | Dec 2004 | WO |
WO 2004103223 | Dec 2004 | WO |
WO 2004105584 | Dec 2004 | WO |
WO 2004105651 | Dec 2004 | WO |
WO 2004112582 | Dec 2004 | WO |
WO 2004112585 | Dec 2004 | WO |
WO 2004112643 | Dec 2004 | WO |
WO 2004112652 | Dec 2004 | WO |
WO 2004112657 | Dec 2004 | WO |
WO 2004112658 | Dec 2004 | WO |
WO 2005000152 | Jan 2005 | WO |
WO 2005002424 | Jan 2005 | WO |
WO 2005002466 | Jan 2005 | WO |
WO 2005004753 | Jan 2005 | WO |
WO 2005007017 | Jan 2005 | WO |
WO 2005007018 | Jan 2005 | WO |
WO 2005007036 | Jan 2005 | WO |
WO 2005007037 | Jan 2005 | WO |
WO 2005009285 | Feb 2005 | WO |
WO 2005009286 | Feb 2005 | WO |
WO 2005009505 | Feb 2005 | WO |
WO 2005009506 | Feb 2005 | WO |
WO 2005011473 | Feb 2005 | WO |
WO 2005011534 | Feb 2005 | WO |
WO 2005011535 | Feb 2005 | WO |
WO 2005013860 | Feb 2005 | WO |
WO 2005018507 | Mar 2005 | WO |
WO 2005021063 | Mar 2005 | WO |
WO 2005023155 | Mar 2005 | WO |
WO 2005025644 | Mar 2005 | WO |
WO 2005027790 | Mar 2005 | WO |
WO 2005027797 | Mar 2005 | WO |
WO 2005034812 | Apr 2005 | WO |
WO 2005039428 | May 2005 | WO |
WO 2005039452 | May 2005 | WO |
WO 2005046488 | May 2005 | WO |
WO 2005046528 | May 2005 | WO |
WO 2005046529 | May 2005 | WO |
WO 2005046530 | May 2005 | WO |
WO 2005046531 | May 2005 | WO |
WO 2005048883 | Jun 2005 | WO |
WO 2005049103 | Jun 2005 | WO |
WO 2005051226 | Jun 2005 | WO |
WO 2005055811 | Jun 2005 | WO |
WO 2005055883 | Jun 2005 | WO |
WO 2005058206 | Jun 2005 | WO |
WO 2005065585 | Jul 2005 | WO |
WO 2005065593 | Jul 2005 | WO |
WO 2005065594 | Jul 2005 | WO |
WO 2005070342 | Aug 2005 | WO |
WO 2005070343 | Aug 2005 | WO |
WO 2005072654 | Aug 2005 | WO |
WO 2005072655 | Aug 2005 | WO |
WO 2005079706 | Sep 2005 | WO |
WO 2005082288 | Sep 2005 | WO |
WO 2005082289 | Sep 2005 | WO |
WO 2005084595 | Sep 2005 | WO |
WO 2005087139 | Sep 2005 | WO |
WO 2005087140 | Sep 2005 | WO |
WO 2006000763 | Jan 2006 | WO |
WO 2006000776 | Jan 2006 | WO |
WO 2006002492 | Jan 2006 | WO |
WO 2006004679 | Jan 2006 | WO |
WO 2006005015 | Jan 2006 | WO |
WO 2006009690 | Jan 2006 | WO |
WO 2006011127 | Feb 2006 | WO |
WO 2006012011 | Feb 2006 | WO |
WO 2006012013 | Feb 2006 | WO |
WO 2006012038 | Feb 2006 | WO |
WO 2006012068 | Feb 2006 | WO |
WO 2006012322 | Feb 2006 | WO |
WO 2006019498 | Feb 2006 | WO |
WO 2006026371 | Mar 2006 | WO |
WO 2006026377 | Mar 2006 | WO |
WO 2006026912 | Mar 2006 | WO |
WO 2006027499 | Mar 2006 | WO |
WO 2006028821 | Mar 2006 | WO |
WO 2006029062 | Mar 2006 | WO |
WO 2006031436 | Mar 2006 | WO |
WO 2006031469 | Mar 2006 | WO |
WO 2006032051 | Mar 2006 | WO |
WO 2006034245 | Mar 2006 | WO |
WO 2006035415 | Apr 2006 | WO |
WO 2006041505 | Apr 2006 | WO |
WO 2006044679 | Apr 2006 | WO |
WO 2006048664 | May 2006 | WO |
WO 2006050459 | May 2006 | WO |
WO 2006050460 | May 2006 | WO |
WO 2006054107 | May 2006 | WO |
WO 2006054930 | May 2006 | WO |
WO 2006055982 | May 2006 | WO |
WO 2006060546 | Jun 2006 | WO |
WO 2006063108 | Jun 2006 | WO |
WO 2006063181 | Jun 2006 | WO |
WO 2006063199 | Jun 2006 | WO |
WO 2006064490 | Jun 2006 | WO |
WO 2006065212 | Jun 2006 | WO |
WO 2006065930 | Jun 2006 | WO |
WO 2006066148 | Jun 2006 | WO |
WO 2006066150 | Jun 2006 | WO |
WO 2006069094 | Jun 2006 | WO |
WO 2006070372 | Jul 2006 | WO |
WO 2006073628 | Jul 2006 | WO |
WO 2006076890 | Jul 2006 | WO |
Number | Date | Country | |
---|---|---|---|
20060178730 A1 | Aug 2006 | US |